🔎 Trials Near Me

Home › Acute Lymphoblastic Leukemia › Washington › Seattle

Pag-aaral pangklinika para sa Acute Lymphoblastic Leukemia sa Seattle, WA

Isang pag-aaral para sa Acute Lymphoblastic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Nagre-recruitPhase 1
  • Seattle Children's Hospital, Seattle
Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06173518

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

Nagre-recruit
  • Seattle Children's, University of Washington, Seattle
  • Fred Hutchinson Cancer Research Center, Seattle
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT05621291

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • at 1 pa
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Nagre-recruitPhase 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
6 Months – 65 Years · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06013423

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Nagre-recruitPhase 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Edad 1 hanggang 60 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT03970096

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Nagre-recruitPhase 1
  • Fred Hutchinson Cancer Center, Seattle
Edad 12 hanggang 78 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT03802695

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Nagre-recruitPhase 2
  • Seattle Children's Hospital, Seattle
6 Months · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06514794

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Nagre-recruitObservasyonal na pag-aaral
  • Seattle Children's Hospital d/b/a Seattle Children's Research Institute, Seattle
1 Day – 17 Years · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06274788

Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

Nagre-recruitPhase 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07224100

Multicenter HomeVENT: Home Values and Experiences Navigation Track

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Seattle Childrens Hospital, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT06102330

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral
  • Fred Hutchinson Cancer Research Center, Seattle
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Nagre-recruitPhase 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT03670966

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Nagre-recruitPhase 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT03128034

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
6 Months · Lahat ng kasarian · Na-update May 29, 2026 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Nagre-recruitPhase 1
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Hanggang edad 80 · Lahat ng kasarian · Na-update May 18, 2026 · NCT03326921

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral
  • Seattle Children's Hospital, Seattle
Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

Nagre-recruitPhase 3
  • Ascentage Investigative Site #1806, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT06051409

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Nagre-recruitPhase 1
  • Fred Hutchinson Cancer Research Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT04260022

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Nagre-recruitPhase 1
  • Fred Hutchinson Cancer Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1
  • Seattle Children's Hospital, Seattle
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa Acute Lymphoblastic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.